|
271 Companies |
|
374 Products |
|
374 Products |
|
160 Mechanisms of Action |
|
34 Trials |
|
5514 News |
|
| «12...6061626364656667686970...110111» |
- | New P2 trial: Assessment of Performance of [18F]-FES for Endometriosis Diagnosis (clinicaltrials.gov) - Sep 8, 2014
P2, N=100, Recruiting, Sponsor: University Hospital, Angers
- New P2 trial: PET CT With HX4 in Cervix Cancer (clinicaltrials.gov) - Sep 8, 2014
P2, N=20, Not yet recruiting, Sponsor: Maastricht Radiation Oncology
- Trial completion, Trial primary completion date, MRI: MRI (Including Spectroscopy and Fat-Saturations and Diffusion-Weighted Imaging) in Cervical Cancer (clinicaltrials.gov) - Sep 8, 2014
P1/2, N=9, Completed, Sponsor: Washington University School of Medicine
Recruiting --> Completed | Trial primary completion date: Nov 2014 --> Aug 2014
- Enrollment open, Trial initiation date, Trial primary completion date: SOVS-CTG: Self-Obtained Vaginal Swabs for Chlamydia and Gonorrhea Testing (clinicaltrials.gov) - Sep 5, 2014
P=N/A, N=3500, Recruiting, Sponsor: University of California, San Francisco
Recruiting --> Completed | Trial primary completion date: Nov 2014 --> Aug 2014 Not yet recruiting --> Recruiting | Initiation date: Apr 2014 --> Aug 2014 | Trial primary completion date: Apr 2015 --> Aug 2015
- || varlilumab (CDX 1127) / Celldex
Trial primary completion date: A Study of CDX-1127 (Varlilumab) in Patients With Select Solid Tumor Types or Hematologic Cancers (clinicaltrials.gov) - Sep 5, 2014
P1, N=170, Recruiting, Sponsor: Celldex Therapeutics
Not yet recruiting --> Recruiting | Initiation date: Apr 2014 --> Aug 2014 | Trial primary completion date: Apr 2015 --> Aug 2015 Trial primary completion date: Dec 2014 --> Mar 2015
- doxycycline / Generic mfg.
Trial primary completion date: MI-PCOS: Effect of a Commonly Used Antibiotic, Doxycycline, in Women With Polycystic Ovarian Syndrome (clinicaltrials.gov) - Sep 4, 2014
P3, N=40, Recruiting, Sponsor: University of Rochester
Trial primary completion date: Dec 2014 --> Mar 2015 Trial primary completion date: Jun 2014 --> Jan 2015
- ||| Yondelis (trabectedin) / Otsuka, PharmaMar, Valeo Pharma
Enrollment open: NIS-OvaYond: An Observational Study of YONDELIS®+PLD for the Treatment of Patients With Platinum-sensitive Relapse of Ovarian Cancer (clinicaltrials.gov) - Sep 4, 2014
P=N/A, N=180, Recruiting, Sponsor: PharmaMar, Spain
Trial primary completion date: Jun 2014 --> Jan 2015 Active, not recruiting --> Recruiting
- Enrollment closed, Trial primary completion date: Internet-based Study of Fertility and Early Pregnancy (PEEPS) (clinicaltrials.gov) - Sep 4, 2014
P=N/A, N=200, Active, not recruiting, Sponsor: Courtney D.Lynch, PhD MPH
Active, not recruiting --> Recruiting Recruiting --> Active, not recruiting | Trial primary completion date: Sep 2014 --> Sep 2015
- Enrollment closed, HEOR: Robot-assisted Laparoscopic Hysterectomy-RALH- Postoperative Complications, Quality of Life and Health Economics (clinicaltrials.gov) - Sep 4, 2014
P=N/A, N=160, Active, not recruiting, Sponsor: Copenhagen University Hospital at Herlev
Recruiting --> Active, not recruiting | Trial primary completion date: Sep 2014 --> Sep 2015 Recruiting --> Active, not recruiting
- | Trial suspension: LUXSOL(TM) Topical Cream for the Treatment of Symptomatic Bacterial Vaginosis; A Proof of Concept Study (clinicaltrials.gov) - Sep 4, 2014
P0, N=60, Suspended, Sponsor: CDA Research Group, Inc.
Recruiting --> Active, not recruiting Recruiting --> Suspended
- Enrollment closed, Preclinical: Real Time In-Vivo Dosimetry For Gynecologic Brachytherapy (clinicaltrials.gov) - Sep 4, 2014
P=N/A, N=20, Active, not recruiting, Sponsor: Duke University
Recruiting --> Suspended Not yet recruiting --> Active, not recruiting
- carboplatin / Generic mfg., lenalidomide / Generic mfg.
Enrollment closed, Combination therapy: A 2 Stage Trial of Lenalidomide (REV) in Asymptomatic Ovarian Cancer Patients With Increasing CA 125 in Late Relapse (clinicaltrials.gov) - Sep 4, 2014
P2, N=72, Active, not recruiting, Sponsor: ARCAGY/ GINECO GROUP
Not yet recruiting --> Active, not recruiting Recruiting --> Active, not recruiting
- ||| pavinetant (AZD4901) / AstraZeneca, Millendo Therap
Enrollment change: A Study of AZD4901 in Females With Polycystic Ovary Syndrome (clinicaltrials.gov) - Aug 29, 2014
P2a, N=67, Completed, Sponsor: AstraZeneca
Recruiting --> Active, not recruiting N=397 --> 67
- Biomarker, Enrollment change, Trial termination, Trial primary completion date: Evaluation of Initial High Risk Human Papillomavirus (HR-HPV) Viral Load as Predictive Marker for Cervical Intraepithelial Neoplasia Grade 1 (CIN1) Persistence (clinicaltrials.gov) - Aug 29, 2014
P=N/A, N=14, Terminated, Sponsor: Assistance Publique Hopitaux De Marseille
N=397 --> 67 N=600 --> 14 | Recruiting --> Terminated | Trial primary completion date: Mar 2012 --> Feb 2013
- | New P4 trial: Effectiveness of IV Acetaminophen and IV Ibuprofen in Reducing Post Procedural Pain in the UFE Procedure (clinicaltrials.gov) - Aug 29, 2014
P4, N=40, Recruiting, Sponsor: University of California, Los Angeles
- |||| pavinetant (AZD4901) / AstraZeneca, Millendo Therap
Trial completion: A Study of AZD4901 in Females With Polycystic Ovary Syndrome (clinicaltrials.gov) - Aug 28, 2014
P2a, N=397, Completed, Sponsor: AstraZeneca
N=600 --> 14 | Recruiting --> Terminated | Trial primary completion date: Mar 2012 --> Feb 2013 Active, not recruiting --> Completed
- Trial completion, Trial primary completion date: Identification and Impact of Vaginal Flora Anomalies Among Pregnant Woman (clinicaltrials.gov) - Aug 28, 2014
P=N/A, N=1000, Completed, Sponsor: Assistance Publique Hopitaux De Marseille
Active, not recruiting --> Completed Recruiting --> Completed | Trial primary completion date: Jul 2010 --> Jul 2013
- ||| Clinical: Clinical Performance of the MaterniT21 PLUS LDT in Multiple Gestation Pregnancies (clinicaltrials.gov) - Aug 27, 2014
P=N/A, N=1000, Recruiting, Sponsor: Sequenom, Inc.
- Enrollment closed: ALIFERT: Diet and Its Relationship With Couple Infertility (clinicaltrials.gov) - Aug 26, 2014
P=N/A, N=400, Active, not recruiting, Sponsor: Assistance Publique - Hôpitaux de Paris
Recruiting --> Completed | Trial primary completion date: Jul 2010 --> Jul 2013 Recruiting --> Active, not recruiting
- prednisone / Generic mfg.
Trial primary completion date: Male Infertility Related With Post Infection Inflammatory Syndrome (clinicaltrials.gov) - Aug 26, 2014
P=N/A, N=600, Recruiting, Sponsor: Assistance Publique - H
Recruiting --> Active, not recruiting Trial primary completion date: Apr 2014 --> Sep 2014
- Clinical: Effects of PGS in Infertile Female Patients With RPL (clinicaltrials.gov) - Aug 22, 2014
P=N/A, N=240, Recruiting, Sponsor: ShangHai Ji Ai Genetics & IVF Institute
- || triptorelin / Generic mfg.
Trial primary completion date, Surgery: A Study to Describe the Efficacy of Diphereline Following Conservative Surgery in Deep Infiltrating Endometriosis (DIE) Patients Over a Period of 24 Months (clinicaltrials.gov) - Aug 22, 2014
P=N/A, N=400, Recruiting, Sponsor: Ipsen
Trial primary completion date: Apr 2014 --> Sep 2014 Trial primary completion date: Jun 2016 --> Jun 2018
- Trial primary completion date: ANOXICOL: Study of a Predictor for Cervix Cancer (clinicaltrials.gov) - Aug 22, 2014
P2, N=60, Recruiting, Sponsor: Centre Oscar Lambret
Trial primary completion date: Jun 2016 --> Jun 2018 Trial primary completion date: May 2014 --> May 2015
- | Enrollment closed: Trichomonas Vaginalis Repeat Infections Among HIV Negative Women (clinicaltrials.gov) - Aug 21, 2014
P3, N=1664, Active, not recruiting, Sponsor: Tulane University Health Sciences Center
Trial primary completion date: May 2014 --> May 2015 Suspended --> Active, not recruiting
- Enrollment closed, Trial primary completion date: KvL: Short Versus Long Protocol for IVF and IVF+ICSI (clinicaltrials.gov) - Aug 21, 2014
P4, N=1100, Active, not recruiting, Sponsor: Peter Hornnes, MD, DMSc
Suspended --> Active, not recruiting Recruiting --> Active, not recruiting | Trial primary completion date: May 2013 --> Dec 2014
- || RG 7600 / Roche
Trial primary completion date: A Study of DMOT4039A in Participants With Unresectable Pancreatic or Platinum-Resistant Ovarian Cancer (clinicaltrials.gov) - Aug 21, 2014
P1, N=71, Active, not recruiting, Sponsor: Genentech
Recruiting --> Active, not recruiting | Trial primary completion date: May 2013 --> Dec 2014 Trial primary completion date: Sep 2014 --> Dec 2014
- metformin / Generic mfg.
Trial primary completion date: Combination Metformin and Oral Contraception for Polycystic Ovary Syndrome (PCOS) (clinicaltrials.gov) - Aug 21, 2014
P4, N=28, Terminated, Sponsor: Virginia Commonwealth University
Trial primary completion date: Sep 2014 --> Dec 2014 Trial primary completion date: Dec 2008 --> Dec 2009
- | New P4 trial: FIV-INOPK: Use of Myo-inositol as Adjuvant Therapy in Patients With Polycystic Ovary Syndrome (PCOS) in Vitro Fertilization (IVF) (clinicaltrials.gov) - Aug 21, 2014
P4, N=280, Not yet recruiting, Sponsor: Centre Hospitalier Departemental Vendee
- opigolix (ASP1707) / Astellas
Enrollment closed: A Study to Assess the Effectiveness and Safety of Different Doses of ASP1707 Compared to Placebo for Endometriosis Associated Pelvic Pain (clinicaltrials.gov) - Aug 21, 2014
P2, N=600, Active, not recruiting, Sponsor: Astellas Pharma Europe B.V.
Trial primary completion date: Dec 2008 --> Dec 2009 Recruiting --> Active, not recruiting
- Trial completion: Folic Acid Clinical Trial for the Prevention of Cervical Cancer (clinicaltrials.gov) - Aug 21, 2014
P2, N=368, Completed, Sponsor: University of Alabama at Birmingham
Recruiting --> Active, not recruiting Recruiting --> Completed
- HEOR, Cost effectiveness: SUBSONiC: Study Into a New Diagnostic Tool (Simple Ultrasound-based Rules) in Patients With Adnexal Masses (clinicaltrials.gov) - Aug 19, 2014
P=N/A, N=270, Recruiting, Sponsor: Maastricht University Medical Center
- New P3 trial, Biopsy: Gene Expression Analysis of the Endometrium After Endometrial Biopsy in Fertile Women (clinicaltrials.gov) - Aug 19, 2014
P3, N=20, Recruiting, Sponsor: University of Aarhus
- || MEDI-3617 / AstraZeneca
Trial primary completion date, Combination therapy, Metastases: A Study to Evaluate the Safety and Antitumor Activity in Subjects With Advanced Solid Tumors (clinicaltrials.gov) - Aug 19, 2014
P1, N=170, Recruiting, Sponsor: MedImmune LLC
Recruiting --> Completed Trial primary completion date: Aug 2015 --> Aug 2016
- Trial primary completion date: Thermal Spread Into the Interstitial Portion of the Fallopian Tubes Using the Ligasure Device at Time of Hysterectomy (clinicaltrials.gov) - Aug 19, 2014
P=N/A, N=39, Active, not recruiting, Sponsor: Memorial Sloan-Kettering Cancer Center
Trial primary completion date: Aug 2015 --> Aug 2016 Trial primary completion date: Aug 2014 --> Aug 2015
- Iclusig (ponatinib) / Takeda, Otsuka
Trial initiation date: Ponatinib in the Treatment of FGFR Mutation Positive Recurrent or Persistent Endometrial Carcinoma (clinicaltrials.gov) - Aug 19, 2014
P=N/A, N=15, Not yet recruiting, Sponsor: Washington University School of Medicine
Trial primary completion date: Aug 2014 --> Aug 2015 Initiation date: Apr 2014 --> Oct 2014
- clomifene citrate / Generic mfg.
Trial initiation date: The Effect of Ethinyl Estradiol on Polycystic Ovary Syndrome Women Undergoing Intrauterine Insemination (clinicaltrials.gov) - Aug 19, 2014
P4, N=154, Completed, Sponsor: Royan Institute
Initiation date: Apr 2014 --> Oct 2014 Initiation date: Sep 2009 --> Mar 2011
- adavosertib (AZD1775) / AstraZeneca
Enrollment open, Trial initiation date, Combination therapy: AZD1775, Cisplatin, and Radiation Therapy in Treating Patients With Cervical Cancer (clinicaltrials.gov) - Aug 19, 2014
P1, N=57, Recruiting, Sponsor: National Cancer Institute (NCI)
Initiation date: Sep 2009 --> Mar 2011 Suspended --> Recruiting | Initiation date: Sep 2013 --> Aug 2014
- ||| adavosertib (AZD1775) / AstraZeneca
Enrollment closed, Combination therapy: A Study of Adavosertib (MK-1775) in Combination With Paclitaxel and Carboplatin Versus Paclitaxel and Carboplatin Alone for Participants With Platinum-Sensitive Ovarian Tumors With the P53 Gene Mutation (MK-1775-004) (clinicaltrials.gov) - Aug 19, 2014
P2, N=120, Active, not recruiting, Sponsor: Merck Sharp & Dohme Corp.
Suspended --> Recruiting | Initiation date: Sep 2013 --> Aug 2014 Recruiting --> Active, not recruiting
- ||||| Ovidrel (choriogonadotropin alfa) / EMD Serono
Enrollment closed, Enrollment change: Phase 3 Study to Evaluate the Efficacy and Safety of Pergoveris® in Assisted Reproductive Technology (ESPART) (clinicaltrials.gov) - Aug 15, 2014
P3, N=1310, Active, not recruiting, Sponsor: Merck KGaA
Recruiting --> Active, not recruiting Recruiting --> Active, not recruiting | N=946 --> 1310
- ||||||| Merional (menotropin) / IBSA Institute Biochemical SA
Trial completion, Preclinical: Safety and Efficacy Study in in Vitro Fertilisation (IVF) Patients (clinicaltrials.gov) - Aug 15, 2014
P3, N=270, Completed, Sponsor: IBSA Institut Biochimique SA
Recruiting --> Active, not recruiting | N=946 --> 1310 Active, not recruiting --> Completed
- Duomeisu (pegylated liposomal doxorubicin) / CSPC Pharma
Trial primary completion date, Combination therapy: EGEN-001 and Pegylated Liposomal Doxorubicin Hydrochloride in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer (clinicaltrials.gov) - Aug 15, 2014
P1, N=18, Recruiting, Sponsor: Gynecologic Oncology Group
Active, not recruiting --> Completed Trial primary completion date: Jul 2014 --> Oct 2014
- clarithromycin / Generic mfg., paroxetine / Generic mfg.
Biomarker, Trial primary completion date: Influence of Pharmacogenetic Factors, Paroxetine and Clarithromycin on Pharmacokinetics of Clomiphene (clinicaltrials.gov) - Aug 15, 2014
P1, N=20, Recruiting, Sponsor: Robert Bosch Gesellschaft f
Trial primary completion date: Jul 2014 --> Oct 2014 Trial primary completion date: Dec 2013 --> Dec 2014
- medroxyprogesterone injection / Generic mfg.
Enrollment change: Medroxyprogesterone in Treating Patients With Endometrioid Adenocarcinoma of the Uterine Corpus (clinicaltrials.gov) - Aug 15, 2014
P2, N=75, Completed, Sponsor: Gynecologic Oncology Group
Trial primary completion date: Dec 2013 --> Dec 2014 N=60 --> 75
- ||| epacadostat (INCB024360) / Incyte
Enrollment closed: A Phase 2 Study of the IDO Inhibitor Epacadostat Versus Tamoxifen for Subjects With Biochemical-recurrent-only EOC, PPC or FTC Following Complete Remission With First-line Chemotherapy (clinicaltrials.gov) - Aug 15, 2014
P2, N=110, Active, not recruiting, Sponsor: Incyte Corporation
N=60 --> 75 Recruiting --> Active, not recruiting
- Enrollment closed: Immediate Vaginal Reconstruction After Oncologic Resection: Surgical Outcomes, Patient Satisfaction and Sexual Function (clinicaltrials.gov) - Aug 15, 2014
P=N/A, N=40, Active, not recruiting, Sponsor: Memorial Sloan-Kettering Cancer Center
Recruiting --> Active, not recruiting Recruiting --> Active, not recruiting
- Trial completion, Enrollment change, Trial primary completion date: Intervention to Improve Follow-up of Abnormal Pap Test (clinicaltrials.gov) - Aug 15, 2014
P=N/A, N=341, Completed, Sponsor: The University of Texas, Galveston
Recruiting --> Active, not recruiting Active, not recruiting --> Completed | N=3555 --> 341 | Trial primary completion date: Aug 2012 --> Apr 2012
- ||| progesterone / Generic mfg.
Enrollment open: The Role of Progesterone and PIF for Successful Implantation and On-going Pregnancy in Assisted Reproductive Technology (clinicaltrials.gov) - Aug 12, 2014
P=N/A, N=900, Enrolling by invitation, Sponsor: Regionshospitalet Viborg, Skive
Active, not recruiting --> Completed | N=3555 --> 341 | Trial primary completion date: Aug 2012 --> Apr 2012 Active, not recruiting --> Enrolling by invitation
- Enrollment open: Protein-Sparing Modified Fast Intervention for Weight Loss in Obese Endometrial Cancer Survivors (clinicaltrials.gov) - Aug 12, 2014
P=N/A, N=20, Recruiting, Sponsor: Case Comprehensive Cancer Center
Active, not recruiting --> Enrolling by invitation Not yet recruiting --> Recruiting
- Duomeisu (pegylated liposomal doxorubicin) / CSPC Pharma, veliparib (ABT-888) / AbbVie
Trial primary completion date, PARP Biomarker, Metastases: Veliparib and Pegylated Liposomal Doxorubicin Hydrochloride in Treating Patients With Recurrent Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer or Metastatic Breast Cancer (clinicaltrials.gov) - Aug 12, 2014
P1, N=58, Recruiting, Sponsor: National Cancer Institute (NCI)
Not yet recruiting --> Recruiting Trial primary completion date: Mar 2014 --> Dec 2014
- brivanib alaninate (BMS-582664) / BMS
Trial primary completion date: Brivanib Alaninate in Treating Patients With Recurrent or Persistent Endometrial Cancer (clinicaltrials.gov) - Aug 12, 2014
P2, N=43, Active, not recruiting, Sponsor: Gynecologic Oncology Group
Trial primary completion date: Mar 2014 --> Dec 2014 Trial primary completion date: Jan 2014 --> Jan 2015